Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Oncology·MeSH: Lymphoma, Mantle-Cell
Prevalence
20.0 / 100K
Incidence
4.7 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)?
There are 2 clinical trials targeting Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) tracked by BioSniper.
What is the prevalence of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)?
The estimated prevalence of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) is approximately 20.0 per 100,000 population.
Deep-dive into Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis